New mechanistic insights on the origin of SARS-CoV-2-induced neurological disorders biorxivpreprint umontpellier IRIM_life unistra SARSCoV2 COVID19 coronavirus neurological disease disorder
By Bhavana KunkalikarSep 20 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the bioRxiv* preprint server, researchers explored the effect of severe acute respiratory syndrome coronavirus 2 exposure on the brain.
The team created an organotypic ex vivo culture with frontal and parietal cortex slices from post-mortem brain excision of non-COVID patients to better regulate the effects of SARS-CoV-2 exposure on the human brain. The 3D microelectrode array measured the functional activity of cultured brain slices since they displayed remarkable spontaneous electrical activity. The team employed a 3D system that replicated an embryonic cortex without microglia.
Ex vivo infection of frontal and parietal brain slices infected with SARS-CoV-2 reporter viruses demonstrated that only a small proportion of cells could become infected, and the virus could not spread further into the slice post-initial virus inoculation. SARS-CoV-2 resulted in neither toxicity nor significant tissue disorganization. This data showed that SARS-CoV-2 could infect neural cells only to a limited extent.
The team discovered that nearly a third of the 180 proteins upregulated after SARS-CoV-2 infection was related to the synaptosome. Also, the presynaptic marker bassoon showed considerable enlargement and lengthening after exposure to SARS-CoV-2, as highlighted by quantitative image analysis.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Is there any impact of COVID-19 vaccines on the fertility of men and women of reproductive age?Is there any impact of COVID-19 vaccines on the fertility of men and women of reproductive age? Unicatt COVID19 coronavirus covid ferility SARSCoV2 reproductivehealth
Lire la suite »
Endogenous exosomes act as decoys for SARS-CoV-2Endogenous exosomes act as decoys for SARS-CoV-2 Exosomes SARSCoV2 Coronavirus Disease COVID Tolllikereceptors Autophagic Interferons PLOSBiology UZH_ch UZH_Virology
Lire la suite »
Molecular engineered low-cost highly effective RBD-based COVID vaccineIn a recent study posted to the bioRxiv* preprint server, an international team of researchers developed a second-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen (RBD-J6) by molecular engineering with two additional amino acid (aa) substitutions (S383D and L518D mutations) in a hydrophobic cryptic RBD core epitope to enhance stability and expression against SARS-CoV-2 variants of concern (VOCs).
Lire la suite »
In Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunityIn Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunity Denmark immunity Omicron Coronavirus Disease COVID HerdImmunity medrxivpreprint cwru TAMU StanfordMed ColumbiaMed
Lire la suite »
The relationship between antigen concentration and diagnostic test performance for SARS-CoV-2 on different types of samplesThe relationship between antigen concentration and diagnostic test performance for SARS-CoV-2 on different types of samples medrxivpreprint PPI_Insights UW SARSCoV2 COVID19 coronavirus covid antigen diagnostictest
Lire la suite »
COVID-19 increases risk of developing Alzheimer's by 50-80% in older adultsIn a recent study published in the Journal of Alzheimer’s Disease, researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections could trigger the development of new-onset Alzheimer’s disease (AD)
Lire la suite »